Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Dynamic powder testing and measurement of bulk powder properties can complement shear cell testing to identify the causes of poor hopper performance in solid-dosage drug manufacturing.

Best Practices for Optimizing Hopper Performance

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Experts at the ISPE annual meeting describe best practices, including containment and production in classified spaces.

Modernizing Oral Solid-Dosage Manufacturing

BioOutsource releases informational video detailing issues associated with ADCC assays and how to effectively analyze them.

BioOutsource Releases Video Addressing Issues with using ADCC Assays

The UK’s National Biologics Manufacturing Centre will use Novasep’s BioSC Lab for protein purification.

UK Center Installs Protein Purification Technology

AstraZeneca’s solid-dose facility in Taizhou, China received ISPE’s FOYA 2015 Overall Winner award.

AstraZeneca China Wins ISPE Facility of the Year Award

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Even though rising production and use of generic pharmaceuticals is saving billions for the nation’s healthcare system, policy makers continue to slap the industry with policies it claims will limit product development and sales.

Hard Times in Washington for Generic Drugs

GE Healthcare's KUBio prebuilt modules were shipped from Germany to JHL Biotech in Wuhan, China.

GE Healthcare Delivers Modular Biopharma Facility to China

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Biotech boom, niche markets, smaller batch sizes and high potency manufacturing are among the key trends shaping the pharmaceutical industry of the 21st century, according to Christian Treitel from Bosch Packaging Technology.

Pharma Trends—From Biologics for Niche Patient Populations to Isolators and Containment for HPAPI Manufacturing

South Africa’s Biovac Institute, which develops and produces vaccines for the country, launched a public-private partnership with Pfizer to enable local manufacturing of Prevenar 13, a vaccine against pneumonia-causing bacteria.

Pfizer Transfers Vaccine Technology for Production in South Africa

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

At least 70 patents for Humira will protect the legacy product from biosimilar competitors, according to information presented during the company’s third-quarter earnings call.